CF PharmTech, Inc. has announced that it will hold its first extraordinary general meeting of 2025 on December 16, 2025, at its location in Suzhou, Jiangsu, PRC. During the meeting, shareholders will consider and, if thought fit, pass the proposed authorization for the Board and/or authorized person to handle matters relating to the H Share Award Scheme.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251126-11929209), on November 26, 2025, and is solely responsible for the information contained therein.
Comments